American Healthcare REIT (US.AHR)
Capital Allocation Audit · Period: 2020 – 2026
Key Metrics
US.AHR · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 52.7% | ↓ |
| ROE | 0.7% | ↑ |
| Cash Conversion | 341.9% | → |
| D/E Ratio | 0.48 | ↑ |
| Gross Margin | 21.3% | ↑ |
US.AHR (American Healthcare REIT) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 52.7% ↓ ROE 0.7% ↑ Cash Conversion 341.9% → D/E Ratio 0.48 ↑ Gross Margin 21.3% ↑
Key Metrics
US.AHR (American Healthcare REIT) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 52.7% ↓ROE 0.7% ↑Cash Conversion 341.9% →D/E Ratio 0.48 ↑Gross Margin 21.3% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies